Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 2/2011

01.03.2011 | Original Paper

Postmortem proteomic analysis in human amygdala of drug addicts: possible impact of tubulin on drug-abusing behavior

verfasst von: P. Zill, V. Vielsmeier, A. Büttner, W. Eisenmenger, F. Siedler, B. Scheffer, H.-J. Möller, B. Bondy

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Besides the ventral tegmental area and the nucleus accumbens as the most investigated brain reward structures, several reports about the relation between volume and activity of the amygdala and drug-seeking behavior have emphasized the central role of the amygdala in the etiology of addiction. Considering its proposed important role and the limited number of human protein expression studies with amygdala in drug addiction, we performed a human postmortem proteomic analysis of amygdala tissue obtained from 8 opiate addicts and 7 control individuals. Results were validated by Western blot in an independent postmortem replication sample from 12 opiate addicts compared to 12 controls and 12 suicide victims, as a second “control sample”. Applying 2D-electrophoresis and MALDI–TOF–MS analysis, we detected alterations of beta-tubulin expression and decreased levels of the heat-shock protein HSP60 in drug addicts. Western blot analysis in the additional sample demonstrated significantly increased alpha- and beta-tubulin concentrations in the amygdala of drug abusers versus controls (P = 0.021, 0.029) and to suicide victims (P = 0.006, 0.002). Our results suggest that cytoskeletal alterations in the amygdala determined by tubulin seem to be involved in the pathophysiology of drug addiction, probably via a relation to neurotransmission and cellular signaling. Moreover, the loss of neuroprotection against stressors by chaperons as HSP60 might also contribute to structural alteration in the brain of drug addicts. Although further studies have to confirm our results, this might be a possible pathway that may increase our understanding of drug addiction.
Literatur
1.
2.
Zurück zum Zitat Goodman A (2008) Neurobiology of addiction. An integrative review. Biochem Pharmacol 75:266–322PubMedCrossRef Goodman A (2008) Neurobiology of addiction. An integrative review. Biochem Pharmacol 75:266–322PubMedCrossRef
3.
Zurück zum Zitat Hurd YL (2006) Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors. CNS Spectr 11:855–862PubMed Hurd YL (2006) Perspectives on current directions in the neurobiology of addiction disorders relevant to genetic risk factors. CNS Spectr 11:855–862PubMed
4.
Zurück zum Zitat Di CG, Bassareo V (2007) Reward system and addiction: what dopamine does and doesn’t do. Curr Opin Pharmacol 7:69–76CrossRef Di CG, Bassareo V (2007) Reward system and addiction: what dopamine does and doesn’t do. Curr Opin Pharmacol 7:69–76CrossRef
5.
Zurück zum Zitat Heidbreder CA, Gardner EL, Xi ZX, Thanos PK, Mugnaini M, Hagan JJ, Ashby CR Jr (2005) The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev 49:77–105PubMedCrossRef Heidbreder CA, Gardner EL, Xi ZX, Thanos PK, Mugnaini M, Hagan JJ, Ashby CR Jr (2005) The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev 49:77–105PubMedCrossRef
6.
7.
Zurück zum Zitat Koob GF, LeMoal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97–129PubMedCrossRef Koob GF, LeMoal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97–129PubMedCrossRef
8.
Zurück zum Zitat Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8:1445–1449PubMedCrossRef Nestler EJ (2005) Is there a common molecular pathway for addiction? Nat Neurosci 8:1445–1449PubMedCrossRef
9.
Zurück zum Zitat Koob GF, LeMoal M (2005) Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction. Nat Neurosci 8:1442–1444PubMedCrossRef Koob GF, LeMoal M (2005) Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction. Nat Neurosci 8:1442–1444PubMedCrossRef
10.
Zurück zum Zitat Koob GF, LeMoal M (2008) Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci 363:3113–3123PubMedCrossRef Koob GF, LeMoal M (2008) Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci 363:3113–3123PubMedCrossRef
11.
Zurück zum Zitat McClung CA, Nestler EJ (2008) Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33:3–17PubMedCrossRef McClung CA, Nestler EJ (2008) Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33:3–17PubMedCrossRef
12.
Zurück zum Zitat Bechara A, Damasio H, Damasio AR, Lee GP (1999) Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. J Neurosci 19:5473–5481PubMed Bechara A, Damasio H, Damasio AR, Lee GP (1999) Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. J Neurosci 19:5473–5481PubMed
13.
Zurück zum Zitat Winstanley CA, Theobald DE, Cardinal RN, Robbins TW (2004) Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci 24:4718–4722PubMedCrossRef Winstanley CA, Theobald DE, Cardinal RN, Robbins TW (2004) Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci 24:4718–4722PubMedCrossRef
14.
Zurück zum Zitat von der Goltz C, Kiefer F (2009) Learning and memory in the aetiopathogenesis of addiction: future implications for therapy? Eur Arch Psychiatry Clin Neurosci 259(2):S183–S187 PubMedCrossRef von der Goltz C, Kiefer F (2009) Learning and memory in the aetiopathogenesis of addiction: future implications for therapy? Eur Arch Psychiatry Clin Neurosci 259(2):S183–S187 PubMedCrossRef
15.
Zurück zum Zitat See RE, Fuchs RA, Ledford CC, McLaughlin J (2003) Drug addiction, relapse, and the amygdala. Ann N Y Acad Sci 985:294–307PubMedCrossRef See RE, Fuchs RA, Ledford CC, McLaughlin J (2003) Drug addiction, relapse, and the amygdala. Ann N Y Acad Sci 985:294–307PubMedCrossRef
16.
Zurück zum Zitat Makris N, Gasic GP, Seidman LJ, Goldstein JM, Gastfriend DR, Elman I, Albaugh MD, Hodge SM, Ziegler DA, Sheahan FS, Caviness VS Jr, Tsuang MT, Kennedy DN, Hyman SE, Rosen BR, Breiter HC (2004) Decreased absolute amygdala volume in cocaine addicts. Neuron 44:729–740PubMedCrossRef Makris N, Gasic GP, Seidman LJ, Goldstein JM, Gastfriend DR, Elman I, Albaugh MD, Hodge SM, Ziegler DA, Sheahan FS, Caviness VS Jr, Tsuang MT, Kennedy DN, Hyman SE, Rosen BR, Breiter HC (2004) Decreased absolute amygdala volume in cocaine addicts. Neuron 44:729–740PubMedCrossRef
17.
Zurück zum Zitat Wrase J, Makris N, Braus DF, Mann K, Smolka MN, Kennedy DN, Caviness VS, Hodge SM, Tang L, Albaugh M, Ziegler DA, Davis OC, Kissling C, Schumann G, Breiter HC, Heinz A (2008) Amygdala volume associated with alcohol abuse relapse and craving. Am J Psychiatry 165:1179–1184PubMedCrossRef Wrase J, Makris N, Braus DF, Mann K, Smolka MN, Kennedy DN, Caviness VS, Hodge SM, Tang L, Albaugh M, Ziegler DA, Davis OC, Kissling C, Schumann G, Breiter HC, Heinz A (2008) Amygdala volume associated with alcohol abuse relapse and craving. Am J Psychiatry 165:1179–1184PubMedCrossRef
18.
Zurück zum Zitat Koob GF (2009) Brain stress systems in the amygdala and addiction. Brain Res 13:61–75CrossRef Koob GF (2009) Brain stress systems in the amygdala and addiction. Brain Res 13:61–75CrossRef
19.
Zurück zum Zitat Taurines R, Dudley E, Conner AC, Grassl J, Jans T, Guderian F, Mehler-Wex C, Warnke A, Gerlach M, Thome J (2010) Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry. Eur Arch Psychiatry Clin Neurosci 260:249–255PubMedCrossRef Taurines R, Dudley E, Conner AC, Grassl J, Jans T, Guderian F, Mehler-Wex C, Warnke A, Gerlach M, Thome J (2010) Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry. Eur Arch Psychiatry Clin Neurosci 260:249–255PubMedCrossRef
20.
Zurück zum Zitat Brunner J, Bronisch T, Uhr M, Ising M, Binder E, Holsboer F, Turck CW (2005) Proteomic analysis of the CSF in unmedicated patients with major depressive disorder reveals alterations in suicide attempters. Eur Arch Psychiatry Clin Neurosci 255:438–440PubMedCrossRef Brunner J, Bronisch T, Uhr M, Ising M, Binder E, Holsboer F, Turck CW (2005) Proteomic analysis of the CSF in unmedicated patients with major depressive disorder reveals alterations in suicide attempters. Eur Arch Psychiatry Clin Neurosci 255:438–440PubMedCrossRef
21.
Zurück zum Zitat Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W (2000) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21:1037–1053PubMedCrossRef Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W (2000) The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21:1037–1053PubMedCrossRef
22.
Zurück zum Zitat Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850–858PubMedCrossRef Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850–858PubMedCrossRef
23.
Zurück zum Zitat Tebbe A, Klein C, Bisle B, Siedler F, Scheffer B, Garcia-Rizo C, Wolfertz J, Hickmann V, Pfeiffer F, Oesterhelt D (2005) Analysis of the cytosolic proteome of Halobacterium salinarum and its implication for genome annotation. Proteomics 5:168–179PubMedCrossRef Tebbe A, Klein C, Bisle B, Siedler F, Scheffer B, Garcia-Rizo C, Wolfertz J, Hickmann V, Pfeiffer F, Oesterhelt D (2005) Analysis of the cytosolic proteome of Halobacterium salinarum and its implication for genome annotation. Proteomics 5:168–179PubMedCrossRef
24.
Zurück zum Zitat Perkins DN, Pappin DJ, Creasy DM, Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551–3567PubMedCrossRef Perkins DN, Pappin DJ, Creasy DM, Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551–3567PubMedCrossRef
25.
Zurück zum Zitat Kim SY, Chudapongse N, Lee SM, Levin MC, Oh JT, Park HJ, Ho IK (2005) Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res Mol Brain Res 133:58–70PubMedCrossRef Kim SY, Chudapongse N, Lee SM, Levin MC, Oh JT, Park HJ, Ho IK (2005) Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res Mol Brain Res 133:58–70PubMedCrossRef
26.
Zurück zum Zitat Matsumoto I, exander-Kaufman K, Iwazaki T, Kashem MA, Matsuda-Matsumoto H (2007) CNS proteomes in alcohol and drug abuse and dependence. Expert Rev Proteomics 4:539–552PubMedCrossRef Matsumoto I, exander-Kaufman K, Iwazaki T, Kashem MA, Matsuda-Matsumoto H (2007) CNS proteomes in alcohol and drug abuse and dependence. Expert Rev Proteomics 4:539–552PubMedCrossRef
27.
Zurück zum Zitat Neasta J, Uttenweiler-Joseph S, Chaoui K, Monsarrat B, Meunier JC, Mouledous L (2006) Effect of long-term exposure of SH-SY5Y cells to morphine: a whole cell proteomic analysis. Proteome Sci 4:23PubMedCrossRef Neasta J, Uttenweiler-Joseph S, Chaoui K, Monsarrat B, Meunier JC, Mouledous L (2006) Effect of long-term exposure of SH-SY5Y cells to morphine: a whole cell proteomic analysis. Proteome Sci 4:23PubMedCrossRef
28.
Zurück zum Zitat Tannu N, Mash DC, Hemby SE (2007) Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol Psychiatry 12:55–73PubMedCrossRef Tannu N, Mash DC, Hemby SE (2007) Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol Psychiatry 12:55–73PubMedCrossRef
29.
Zurück zum Zitat Marie-Claire C, Courtin C, Roques BP, Noble F (2004) Cytoskeletal genes regulation by chronic morphine treatment in rat striatum. Neuropsychopharmacology 29:2208–2215PubMedCrossRef Marie-Claire C, Courtin C, Roques BP, Noble F (2004) Cytoskeletal genes regulation by chronic morphine treatment in rat striatum. Neuropsychopharmacology 29:2208–2215PubMedCrossRef
30.
Zurück zum Zitat Boudreau AC, Ferrario CR, Glucksman MJ, Wolf ME (2009) Signaling pathway adaptations and novel protein kinase A substrates related to behavioral sensitization to cocaine. J Neurochem 110:363–377PubMedCrossRef Boudreau AC, Ferrario CR, Glucksman MJ, Wolf ME (2009) Signaling pathway adaptations and novel protein kinase A substrates related to behavioral sensitization to cocaine. J Neurochem 110:363–377PubMedCrossRef
31.
Zurück zum Zitat Verdier-Pinard P, Pasquier E, Xiao H, Burd B, Villard C, Lafitte D, Miller LM, Angeletti RH, Horwitz SB, Braguer D (2009) Tubulin proteomics: towards breaking the code. Anal Biochem 384:197–206PubMedCrossRef Verdier-Pinard P, Pasquier E, Xiao H, Burd B, Villard C, Lafitte D, Miller LM, Angeletti RH, Horwitz SB, Braguer D (2009) Tubulin proteomics: towards breaking the code. Anal Biochem 384:197–206PubMedCrossRef
32.
Zurück zum Zitat Verdejo-Garcia A, Perez-Garcia M, Sanchez-Barrera M, Rodriguez-Fernandez A, Gomez-Rio M (2007) Neuroimaging and drug addiction: neuroanatomical correlates of cocaine, opiates, cannabis and ecstasy abuse. Rev Neurol 44:432–439PubMed Verdejo-Garcia A, Perez-Garcia M, Sanchez-Barrera M, Rodriguez-Fernandez A, Gomez-Rio M (2007) Neuroimaging and drug addiction: neuroanatomical correlates of cocaine, opiates, cannabis and ecstasy abuse. Rev Neurol 44:432–439PubMed
33.
Zurück zum Zitat Howe CL, Mobley WC (2004) Signaling endosome hypothesis: a cellular mechanism for long distance communication. J Neurobiol 58:207–216PubMedCrossRef Howe CL, Mobley WC (2004) Signaling endosome hypothesis: a cellular mechanism for long distance communication. J Neurobiol 58:207–216PubMedCrossRef
34.
Zurück zum Zitat Collins MO, Yu L, Coba MP, Husi H, Campuzano I, Blackstock WP, Choudhary JS, Grant SG (2005) Proteomic analysis of in vivo phosphorylated synaptic proteins. J Biol Chem 280:5972–5982PubMedCrossRef Collins MO, Yu L, Coba MP, Husi H, Campuzano I, Blackstock WP, Choudhary JS, Grant SG (2005) Proteomic analysis of in vivo phosphorylated synaptic proteins. J Biol Chem 280:5972–5982PubMedCrossRef
35.
Zurück zum Zitat Poulain FE, Sobel A (2009) The microtubule network and neuronal morphogenesis: dynamic and coordinated orchestration through multiple players. Mol Cell Neurosci 43(1):15–21 Poulain FE, Sobel A (2009) The microtubule network and neuronal morphogenesis: dynamic and coordinated orchestration through multiple players. Mol Cell Neurosci 43(1):15–21
36.
Zurück zum Zitat Signor D, Scholey JM (2000) Microtubule-based transport along axons, dendrites and axonemes. Essays Biochem 35:89–102PubMed Signor D, Scholey JM (2000) Microtubule-based transport along axons, dendrites and axonemes. Essays Biochem 35:89–102PubMed
37.
Zurück zum Zitat Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56(1):73–82PubMedCrossRef Russo SJ, Mazei-Robison MS, Ables JL, Nestler EJ (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56(1):73–82PubMedCrossRef
38.
Zurück zum Zitat Thomas MJ, Kalivas PW, Shaham Y (2008) Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 154:327–342PubMedCrossRef Thomas MJ, Kalivas PW, Shaham Y (2008) Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol 154:327–342PubMedCrossRef
39.
Zurück zum Zitat Geremia NM, Pettersson LM, Hasmatali JC, Hryciw T, Danielsen N, Schreyer DJ, Verge VM (2009) Endogenous BDNF regulates induction of intrinsic neuronal growth programs in injured sensory neurons. Exp Neurol 223(1):128–142PubMedCrossRef Geremia NM, Pettersson LM, Hasmatali JC, Hryciw T, Danielsen N, Schreyer DJ, Verge VM (2009) Endogenous BDNF regulates induction of intrinsic neuronal growth programs in injured sensory neurons. Exp Neurol 223(1):128–142PubMedCrossRef
40.
Zurück zum Zitat Gordon T (2009) The role of neurotrophic factors in nerve regeneration. Neurosurg Focus 26(2):E3PubMedCrossRef Gordon T (2009) The role of neurotrophic factors in nerve regeneration. Neurosurg Focus 26(2):E3PubMedCrossRef
41.
Zurück zum Zitat Rasenick MM, Donati RJ, Popova JS, Yu JZ (2004) Tubulin as a regulator of G-protein signaling. Methods Enzymol 390:389–403PubMedCrossRef Rasenick MM, Donati RJ, Popova JS, Yu JZ (2004) Tubulin as a regulator of G-protein signaling. Methods Enzymol 390:389–403PubMedCrossRef
42.
Zurück zum Zitat Popova JS, Rasenick MM (2003) G beta gamma mediates the interplay between tubulin dimers and microtubules in the modulation of Gq signaling. J Biol Chem 278:34299–34308PubMedCrossRef Popova JS, Rasenick MM (2003) G beta gamma mediates the interplay between tubulin dimers and microtubules in the modulation of Gq signaling. J Biol Chem 278:34299–34308PubMedCrossRef
43.
Zurück zum Zitat Popova NK, Naumenko KS, Maslova LN, Amstislavskaya TG, Melidi NN, Bulygina VV, Ivanova LN (2002) Hypothalamic tryptophan hydroxylase and the hypothalamic-pituitary-adrenocortical response to water deprivation and hydration in vasopressin-deficient and normal rats. Pflugers Arch 444:372–377PubMedCrossRef Popova NK, Naumenko KS, Maslova LN, Amstislavskaya TG, Melidi NN, Bulygina VV, Ivanova LN (2002) Hypothalamic tryptophan hydroxylase and the hypothalamic-pituitary-adrenocortical response to water deprivation and hydration in vasopressin-deficient and normal rats. Pflugers Arch 444:372–377PubMedCrossRef
44.
Zurück zum Zitat Gupta RS (1995) Evolution of the chaperonin families (Hsp60, Hsp10 and Tcp-1) of proteins and the origin of eukaryotic cells. Mol Microbiol 15:1–11PubMedCrossRef Gupta RS (1995) Evolution of the chaperonin families (Hsp60, Hsp10 and Tcp-1) of proteins and the origin of eukaryotic cells. Mol Microbiol 15:1–11PubMedCrossRef
45.
Zurück zum Zitat Cunha-Oliveira T, Rego AC, Oliveira CR (2008) Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res Rev 58:192–208PubMedCrossRef Cunha-Oliveira T, Rego AC, Oliveira CR (2008) Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Res Rev 58:192–208PubMedCrossRef
46.
Zurück zum Zitat Hayase T, Yamamoto Y, Yamamoto K, Muso E, Shiota K, Hayashi T (2003) Similar effects of cocaine and immobilization stress on the levels of heat-shock proteins and stress-activated protein kinases in the rat hippocampus, and on swimming behaviors: the contribution of dopamine and benzodiazepine receptors. Behav Pharmacol 14:551–562PubMedCrossRef Hayase T, Yamamoto Y, Yamamoto K, Muso E, Shiota K, Hayashi T (2003) Similar effects of cocaine and immobilization stress on the levels of heat-shock proteins and stress-activated protein kinases in the rat hippocampus, and on swimming behaviors: the contribution of dopamine and benzodiazepine receptors. Behav Pharmacol 14:551–562PubMedCrossRef
47.
Zurück zum Zitat Salminen WF Jr, Voellmy R, Roberts SM (1997) Protection against hepatotoxicity by a single dose of amphetamine: the potential role of heat shock protein induction. Toxicol Appl Pharmacol 147:247–258PubMedCrossRef Salminen WF Jr, Voellmy R, Roberts SM (1997) Protection against hepatotoxicity by a single dose of amphetamine: the potential role of heat shock protein induction. Toxicol Appl Pharmacol 147:247–258PubMedCrossRef
48.
Zurück zum Zitat Salminen WF Jr, Roberts SM, Fenna M, Voellmy R (1997) Heat shock protein induction in murine liver after acute treatment with cocaine. Hepatology 25:1147–1153PubMedCrossRef Salminen WF Jr, Roberts SM, Fenna M, Voellmy R (1997) Heat shock protein induction in murine liver after acute treatment with cocaine. Hepatology 25:1147–1153PubMedCrossRef
49.
Zurück zum Zitat Stan AD, Ghose S, Gao XM, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ, Tamminga CA (2006) Human postmortem tissue: what quality markers matter? Brain Res 1123:1–11PubMedCrossRef Stan AD, Ghose S, Gao XM, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ, Tamminga CA (2006) Human postmortem tissue: what quality markers matter? Brain Res 1123:1–11PubMedCrossRef
Metadaten
Titel
Postmortem proteomic analysis in human amygdala of drug addicts: possible impact of tubulin on drug-abusing behavior
verfasst von
P. Zill
V. Vielsmeier
A. Büttner
W. Eisenmenger
F. Siedler
B. Scheffer
H.-J. Möller
B. Bondy
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 2/2011
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-010-0129-7

Weitere Artikel der Ausgabe 2/2011

European Archives of Psychiatry and Clinical Neuroscience 2/2011 Zur Ausgabe

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.